$CBLL News
Last published 1w ago
- 1w agoCBLLCeribell, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoCBLLCeribell Reports Third Quarter 2026 Financial ResultsGlobeNewswireSUNNYVALE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious
- 1w agoCBLLCeribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring SolutionGlobeNewswireSUNNYVALE, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Ceribell, Inc. (NASDAQ:CBLL) ("Ceribell" or the "Company"), a medical technology company focused on transforming the diagnosis and management of
- 2w agoCBLLCeribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumGlobeNewswireSUNNYVALE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious
- 3w agoCBLLCeribell to Report Third Quarter 2026 Financial Results on November 3, 2026GlobeNewswireSUNNYVALE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious
- 3mo agoCBLLCG 46TH ANNUAL GROWTH CONFERENCE - CERIBELL INCEarnings Call TranscriptsGreat. Good morning. My name is Bill Plovonik. I'm a senior analyst here with Canaccord on the MedTech side. Welcome to our 46th Annual Global Growth Conference. With us up next, we're going to have Sarah Bell, Scott Blu
- 3mo agoCBLLCG 46TH ANNUAL GROWTH CONFERENCE - CERIBELL INCEarnings Call TranscriptsGreat. Good morning. My name is Bill Plovonik. I'm a senior analyst here with Canaccord on the MedTech side. Welcome to our 46th Annual Global Growth Conference. With us up next, we're going to have Sarah Bell, Scott Blu
- 3mo agoCBLLCeribell Q2 2026 Earnings Call - CERIBELL INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by. My name is Desiree and I will be your conference operator today. At this time, I would like to welcome everyone to Cerebral Q2 2026 earnings call. All lines have been plac
- 3mo agoCBLLCeribell Reports Second Quarter 2026 Financial ResultsGlobeNewswireSUNNYVALE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious
- 3mo agoCBLLCeribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG ReviewGlobeNewswireSUNNYVALE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell" or the "Company"), a medical technology company focused on transforming the diagnosis and management of
- 3mo agoCBLLCeribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor SystemGlobeNewswireSUNNYVALE, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell" or the "Company"), a medical technology company focused on transforming the diagnosis and management of
- 3mo agoCBLLCeribell Expands Board of Directors with Appointments of Thomas West and Sharon O’KeefeGlobeNewswireSUNNYVALE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious
- 3mo agoCBLLCeribell to Participate in the Canaccord Genuity 46th Annual Growth ConferenceGlobeNewswireSUNNYVALE, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious
- 3mo agoCBLLCeribell to Report Second Quarter 2026 Financial Results on August 10, 2026GlobeNewswireSUNNYVALE, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious
- 5mo agoCBLLCeribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological OutcomesGlobeNewswireSUNNYVALE, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 5mo agoCBLLWILLIAM BLAIR 46TH ANNUAL GROWTH STOCK CONFERENCE - CERIBELL INCEarnings Call TranscriptsBrandon Vasquez. I am one of William Blair's medical device analysts covering medical devices, but also some animal health things as well. I Am required to inform you that if you would like a complete list of research di
- 5mo agoCBLLCeribell to Participate in the William Blair 46th Annual Growth Stock ConferenceGlobeNewswireSUNNYVALE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 6mo agoCBLL2026 GLOBAL HEALTHCARE CONFERENCECERIBELL INCEarnings Call TranscriptsOkay. I am Stephanie El Ghazi. I cover medical devices at Bank of America. And next up as part of our healthcare conference, we have Sarah Bell. We have Jane Chow, CEO, and Scott Bloomberg, CFO. So thank you both for bei
- 6mo agoCBLLCeribell Q1 2026 Earnings CallCERIBELL INCEarnings Call TranscriptsThank you for standing by. At this time, I would like to welcome everyone to the Sarah Bell First Quarter 2026 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speaker's remark
- 6mo agoCBLLCeribell Reports First Quarter 2026 Financial ResultsGlobeNewswireSUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 6mo agoCBLLCeribell to Participate in the Bank of America Securities 2026 Health Care ConferenceGlobeNewswireSUNNYVALE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 6mo agoCBLLCeribell to Report First Quarter 2026 Financial Results on May 11, 2026GlobeNewswireSUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 8mo agoCBLLCERIBELL Q4 2025 EARNINGS CALLCERIBELL INCEarnings Call TranscriptsHello and welcome to the Cerebral Q4 2025 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to
- 8mo agoCBLLCeribell Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswireSUNNYVALE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 8mo agoCBLLCeribell to Participate in Upcoming March Investor ConferencesGlobeNewswireSUNNYVALE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 9mo agoCBLLCeribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026GlobeNewswireSUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 9mo agoATRCCBLLEWHTFLAI Diagnostics: The End of the High-Cost Imaging EraGlobeNewswireVANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The AI medical imaging market is entering a phase of explosive 25.8% annual growth through 2034[1]. This systemic
- 10mo agoCBLLCeribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring SolutionGlobeNewswireSUNNYVALE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 10mo agoCBLLCeribell to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireSUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 11mo agoHTFLCBLLMDTABTAI Diagnostics Hit Critical Mass as Hospitals Race to Cut CostsPR NewswireUSANewsGroup.com News Commentary – Point-of-care infectious disease diagnostics valued at $53 billion in 2024 are projected to nearly double by 2033, ...
- 11mo agoCBLLGEHCMRNAPLTRGlobal AI Infrastructure Shift Ignites Biotech Growth PhaseGlobeNewswireIssued on behalf of Aleen Inc. VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Last month marked a major turning point as Google launched Gemini 3[1], proving that new
- 11mo agoCBLLCeribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring SolutionGlobeNewswireSUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 11mo agoCBLLCeribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for NeonatesGlobeNewswireSUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 11mo agoCBLLCeribell to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswireSUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 1y agoCBLLCeribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumGlobeNewswireSUNNYVALE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 1y agoCBLLCeribell Reports Third Quarter 2025 Financial ResultsGlobeNewswireSUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 1y agoCBLLCeribell to Report Third Quarter 2025 Financial Results on November 4, 2025GlobeNewswireSUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 1y agoCBLLMedtech Leader Erica Rogers Joins Ceribell Board of DirectorsGlobeNewswireSUNNYVALE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell" or the "Company"), a medical technology company focused on transforming the diagnosis and management of patients with
- 1y agoCBLLCeriBell, Inc. (CBLL) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoCBLLCeribell Reports Second Quarter 2025 Financial ResultsGlobeNewswireSUNNYVALE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 1y agoCBLLCeribell to Participate in the Canaccord Genuity 45th Annual Growth ConferenceGlobeNewswireSUNNYVALE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 1y agoCBLLCeribell to Report Second Quarter 2025 Financial Results on August 5, 2025GlobeNewswireSUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 1y agoCBLLCeribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in DelawareGlobeNewswireSUNNYVALE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a leading medical technology company transforming the diagnosis and management of patients with serious neurological
- 1y agoMDAIGEHCCBLLAI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment LandscapePR NewswireEquity Insider News Commentary – Amid the wave of new AI-powered innovations in healthcare, so far ambient scribes have emerged as the breakout use...
- 1y agoCBLLCeribell to Participate in the William Blair 45th Annual Growth Stock ConferenceGlobeNewswireSUNNYVALE, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 1y agoCBLLCeribell Reports First Quarter 2025 Financial ResultsGlobeNewswireSUNNYVALE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 1y agoCBLLCeribell to Participate in the Bank of America Securities 2025 Health Care ConferenceGlobeNewswireSUNNYVALE, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 1y agoCBLLCeribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare SystemsGlobeNewswireCeribell is one of only 51 companies in the U.S. to achieve FedRAMP High authorization Ceribell's breakthrough technology can now be deployed in federal healthcare facilities, including U.S. Department of Veterans
- 1y agoCBLLCeribell to Report First Quarter 2025 Financial Results on May 8, 2025GlobeNewswireSUNNYVALE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological
- 1y agoCBLLFDA Clears Ceribell's Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and OlderGlobeNewswireSUNNYVALE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological